Zhu, Jiayu <br/><br/>
Triptolide enhances chemotherapeutic efficacy of antitumor drugs in non-small-cell lung cancer cells by inhibiting Nrf2-ARE activity.  [electronic resource] 

 -  Toxicology and applied pharmacology  11 2018 
 - 1-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1096-0333 
<br/><br/><label>Standard No.: </label>10.1016/j.taap.2018.09.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>A549 Cells<br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Agents, Alkylating--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Antioxidant Response Elements--drug effects<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Diterpenes--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Drug Resistance, Neoplasm--drug effects<br/>Epoxy Compounds--administration & dosage<br/>Hep G2 Cells<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>NF-E2-Related Factor 2--antagonists & inhibitors<br/>Phenanthrenes--administration & dosage<br/>Treatment Outcome<br/>Tumor Burden--drug effects<br/>Xenograft Model Antitumor Assays--methods